Business - February 1, 2023
Last patient included in AlzeCure’s Phase II trial
The last patient has now been included in the ongoing clinical study with ACD440, the lead non-opioid drug candidate in the painless platform, which is being developed against peripheral neuropathic pain. This double-blind, placebo-controlled, randomized cross-over study, which is carried out in collaboration with LINK Medical Research in Uppsala, is aimed at evaluating the efficacy, […]
Business - February 1, 2023
An export success anchored in Umeå & Linköping
Nordic Biomarker was recently named ‘Exporter of the Year 2022’ but the Umeå-based company says its journey has only just begun. The company has announced its vision to become a global force in the life science industry – with an ambitious five-year goal to reach almost a 1 billion SEK turnover and potentially employ over […]
Business - January 25, 2023
A high-level take on recent trends in healthcare
Healthcare stock indices enjoyed a decade-long growth-phase until and including 2017. IPOs within the sector, at arguably far too steep valuations, continued riding on this growth phase, peaking somewhat later in 2020-2021. This phase culminated with a growing number of disappointments between 2020-1H 2022, driven first by gene therapies, then oncology and in neurodegenerative diseases. […]
Business - January 18, 2023
A hotbed for innovation and technology
The new science city in Reykjavik is set to attract growing companies, foreign investors and even more talent. Despite being one of the world’s smallest capitals, Reykjavik has an innovative and creative atmosphere, not least within life sciences. The life science industry includes biotech, pharma, genetics, and medical devices, and it is a growing sector […]
Business - January 13, 2023
Strategies for business growth
What are the secret ingredients for successful company growth within life sciences? What lessons can we learn from the journeys, progress, setbacks and challenges of other Nordic companies? What perspectives and advice can the region’s investors and business advisors provide? The pandemic’s impact on life and businesses is slowly coming to an end, at least […]
Business - January 12, 2023
She is the new CEO of Oncopeptides
The Board of Directors of the company has appointed Monica Shaw as Chief Executive Officer, CEO, of Oncopeptides. Shaw replaces Jakob Lindberg, who has been the CEO since November 15, 2021. Lindberg assumes his previous position as Chief Scientific Officer. A transformational year The leadership changes follow a transformational year for Oncopeptides, when Pepaxti, was […]
